Citation: | ZOUXiao-yan, FANXiang-cheng, TIANYou-qing, SHANGJing. Effects of Luteolin and Its Analogues Against Myocardial Ischemia/Reperfusion Injury, Lipid Metabolism and Apoptosis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(3): 380-386. |
[1] |
HEUSCH G.Critical issues for the translation of cardioprotection[J].Circ Res,2017,120(9):1477-1486.
|
[2] |
HEUSCH G.Cardioprotection research must leave its comfort zone[J].Eur Heart J,2018,39(36):3393-3395.
|
[3] |
吴楠,张晓雯.高脂血症对心肌缺血再灌注损伤的影响[J].解剖科学进展,2019,25(6):724-726,730.
|
[4] |
FERDINANDY P,HAUSENLOY DJ,HEUSCH G,et al.Interaction of risk factors,comorbidities,and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning,postconditioning,and remote conditioning[J].Pharmacol Rev,2014,66(4):1142-1174.
|
[5] |
PEREIRA CD,AZEVEDO I,MONTEIRO R,et al.11β-Hydroxysteroid dehydrogenase type 1:Relevance of its modulation in the pathophysiology of obesity,the metabolic syndrome and type 2 diabetes mellitus[J].Diabetes Obes Metab,2012,14(10):869-881.
|
[6] |
ZHUKOVSKY MA,FILOGRANA A,LUINI A,et al.The structure and function of acylglycerophosphate acyltransferase 4/ lysophosphatidic acid acyltransferase delta (AGPAT4/LPAATδ)[J].Front Cell Dev Biol,2019,7:147.
|
[7] |
TANG WW,YUAN J,CHEN XY,et al.Identification of a novel human lysophosphatidic acid acyltransferase,LPAAT-theta,which activates mTOR pathway[J].J Biochem Mol Biol,2006,39(5):626-635.
|
[8] |
SAULNIER-BLACHE JS,GIRARD A,SIMON MF,et al.A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification[J].J Lipid Res,2000,41(12):1947-1951.
|
[9] |
HIDESHIMA T,CHAUHAN D,HAYASHI T,et al.Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors,a novel class of agents,in multiple myeloma[J].Cancer Res,2003,63(23):8428-8436.
|
[10] |
WU DN,PEI DS,WANG Q,et al.Down-regulation of PTEN by sodium orthovanadate inhibits ASK1 activation via PI3-K/Akt during cerebral ischemia in rat Hippocampus[J].Neurosci Lett,2006,404(1/2):98-102.
|
[11] |
MOCANU MM,YELLON DM.PTEN,the Achilles' heel of myocardial ischaemia/reperfusion injury?[J].Br J Pharmacol,2007,150(7):833-838.
|
[12] |
KEYES KT,XU J,LONG B,et al.Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction[J].Am J Physiol Heart Circ Physiol,2010,298(4):H1198-H1208.
|
[13] |
CHAN RJ,FENG GS.PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase[J].Blood,2007,109(3):862-867.
|
[14] |
LEE SW,WON JY,LEE HY,et al.Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade[J].Mol Med,2011,17(9/10):1095-1106.
|
[15] |
阿布卡德,田友清,尚靖.香青兰研究进展[J].北方药学,2011,8(2):55-57.
|
[16] |
阿布力米提,艾来提,穆赫塔尔,等.香青兰中黄酮类化合物的研究[J].食品科学,2007,28(8):384-386.
|
[17] |
谭梦晖,于波,谷颖敏,等.香青兰不同部位提取物对大鼠实验性高脂血症的影响[J].中国实验方剂学杂志,2011,17(21):209-213.
|
[18] |
田友清,尚靖,何婷,等.基于中药血清化学及血清药理学方法探讨香青兰保护心肌细胞缺氧/复氧损伤物质基础[J].中国中药杂志,2012,37(5):620-624.
|
[19] |
田友清,尚靖,阿布卡德.香青兰及其含药血清对H9c2心肌细胞三种缺氧/复氧损伤模型的影响[J].中国新药杂志,2012,21(15):1736-1739,1748.
|
[20] |
李梦雯,于东升,田友清,等.木犀草素对心肌细胞物理性及化学性缺氧/复氧损伤的作用[J].中国药学杂志,2013,48(17):1257-1261.
|
[21] |
YU DS,LI MW,TIAN YQ,et al.Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury[J].Life Sci,2015,122:15-25.
|
[22] |
ZHOU MJ,REN HH,HAN JC,et al.Protective effects of kaempferol against myocardial ischemia/reperfusion injury in isolated rat heart via antioxidant activity and inhibition of glycogen synthase kinase-3β[J].Oxid Med Cell Longev,2015,2015:481405.
|
[23] |
STILES B,GROSZER M,WANG SY,et al.PTENless means more[J].Dev Biol,2004,273(2):175-184.
|
[24] |
黄定德,陈杞,韩玲,等.γ线诱发的白血病小鼠胸腺细胞中SHP-2表达及功能的研究[J].第三军医大学学报,2004,26(14):1258-1260.
|